CONMED Corporation (CNMD)
CONMED Statistics
Share Statistics
CONMED has 30.93M shares outstanding. The number of shares has increased by 0.35% in one year.
| Shares Outstanding | 30.93M |
| Shares Change (YoY) | 0.35% |
| Shares Change (QoQ) | 0.06% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 30.07M |
| Failed to Deliver (FTD) Shares | 90 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 2.57M, so 8.31% of the outstanding shares have been sold short.
| Short Interest | 2.57M |
| Short % of Shares Out | 8.31% |
| Short % of Float | 11.51% |
| Short Ratio (days to cover) | 6.24 |
Valuation Ratios
The PE ratio is 15.94 and the forward PE ratio is 9.95. CONMED's PEG ratio is 0.15.
| PE Ratio | 15.94 |
| Forward PE | 9.95 |
| PS Ratio | 1.62 |
| Forward PS | 1 |
| PB Ratio | 2.19 |
| P/FCF Ratio | 13.72 |
| PEG Ratio | 0.15 |
Enterprise Valuation
CONMED has an Enterprise Value (EV) of 2.99B.
| EV / Sales | 2.29 |
| EV / EBITDA | 10.99 |
| EV / EBIT | 17.92 |
| EV / FCF | 19.45 |
Financial Position
The company has a current ratio of 2.3, with a Debt / Equity ratio of 0.94.
| Current Ratio | 2.3 |
| Quick Ratio | 1.05 |
| Debt / Equity | 0.94 |
| Debt / EBITDA | 3.33 |
| Debt / FCF | 5.89 |
| Interest Coverage | 5.37 |
Financial Efficiency
Return on Equity is 13.76% and Return on Invested Capital is 8.02%.
| Return on Equity | 13.76% |
| Return on Assets | 5.74% |
| Return on Invested Capital | 8.02% |
| Revenue Per Employee | $335.13K |
| Profits Per Employee | $33.95K |
| Employee Count | 3,900 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 1.66 |
Taxes
| Income Tax | 30.61M |
| Effective Tax Rate | 18.77% |
Stock Price Statistics
The stock price has increased by -31.7% in the last 52 weeks. The beta is 1.29, so CONMED's price volatility has been higher than the market average.
| Beta | 1.29 |
| 52-Week Price Change | -31.7% |
| 50-Day Moving Average | 59.27 |
| 200-Day Moving Average | 67.37 |
| Relative Strength Index (RSI) | 32.11 |
| Average Volume (20 Days) | 533.15K |
Income Statement
In the last 12 months, CONMED had revenue of 1.31B and earned 132.42M in profits. Earnings per share was 4.29.
| Revenue | 1.31B |
| Gross Profit | 733.03M |
| Operating Income | 200.33M |
| Net Income | 132.42M |
| EBITDA | 272.18M |
| EBIT | 200.33M |
| Earnings Per Share (EPS) | 4.29 |
Balance Sheet
The company has 24.46M in cash and 905.78M in debt, giving a net cash position of -881.32M.
| Cash & Cash Equivalents | 24.46M |
| Total Debt | 905.78M |
| Net Cash | -881.32M |
| Retained Earnings | 560.28M |
| Total Assets | 2.31B |
| Working Capital | 361.88M |
Cash Flow
In the last 12 months, operating cash flow was 166.97M and capital expenditures -13.08M, giving a free cash flow of 153.88M.
| Operating Cash Flow | 166.97M |
| Capital Expenditures | -13.08M |
| Free Cash Flow | 153.88M |
| FCF Per Share | 4.99 |
Margins
Gross margin is 56.08%, with operating and profit margins of 15.33% and 10.13%.
| Gross Margin | 56.08% |
| Operating Margin | 15.33% |
| Pretax Margin | 12.47% |
| Profit Margin | 10.13% |
| EBITDA Margin | 20.82% |
| EBIT Margin | 15.33% |
| FCF Margin | 11.77% |
Dividends & Yields
CNMD pays an annual dividend of $1, which amounts to a dividend yield of 1.36%.
| Dividend Per Share | $1.00 |
| Dividend Yield | 1.36% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | 23.53% |
| Earnings Yield | 6.27% |
| FCF Yield | 7.29% |
Analyst Forecast
The average price target for CNMD is $75, which is 54.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $75 |
| Price Target Difference | 54.5% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
Stock Splits
The last stock split was on Sep 10, 2001. It was a forward split with a ratio of 3:2.
| Last Split Date | Sep 10, 2001 |
| Split Type | forward |
| Split Ratio | 3:2 |
Scores
| Altman Z-Score | 2.08 |
| Piotroski F-Score | 8 |